» Articles » PMID: 34543933

Post-COVID-19 Opsoclonus-myoclonus Syndrome and Encephalopathy Associated with Leucine-rich Glioma-inactivated 1 (LGI-1) Antibodies

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2021 Sep 20
PMID 34543933
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical and diagnostic features of long-COVID patients presenting with neurologic symptoms in Chicago.

Brandes L, Orme D, Bermeo-Ovalle A, Sierra Morales F J Neural Transm (Vienna). 2024; 131(8):961-969.

PMID: 38847905 DOI: 10.1007/s00702-024-02789-9.


De Novo Movement Disorders Associated with COVID-19- A Systematic Review of Individual Patients.

Pillai K, Misra S, Siripurapu G, Aliyar A, Bhat P, Rajan R Ann Indian Acad Neurol. 2023; 26(5):702-707.

PMID: 38022478 PMC: 10666879. DOI: 10.4103/aian.aian_572_23.


Movement Disorders and SARS-CoV-2.

Fung W, Fasano A, Fearon C Mov Disord Clin Pract. 2023; 10(Suppl 2):S9-S17.

PMID: 37637980 PMC: 10448146. DOI: 10.1002/mdc3.13615.


Adult-onset idiopathic opsoclonus-myoclonus syndrome.

Zhang X, Yan W, Song Y, Zhu H, Sun Y Arq Bras Oftalmol. 2023; .

PMID: 36995813 PMC: 11619083. DOI: 10.5935/0004-2749.2022-0024.


Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.

Finsterer J, Scorza F Neuroophthalmology. 2023; 47(1):1-6.

PMID: 36798867 PMC: 9928447. DOI: 10.1080/01658107.2022.2128378.


References
1.
Armangue T, Moris G, Cantarin-Extremera V, Conde C, Rostasy K, Erro M . Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015; 85(20):1736-43. PMC: 4653102. DOI: 10.1212/WNL.0000000000002125. View

2.
Shah P, Desai S . Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection. Neurology. 2020; 96(1):33. DOI: 10.1212/WNL.0000000000010978. View

3.
van Sonderen A, Thijs R, Coenders E, Jiskoot L, Sanchez E, de Bruijn M . Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016; 87(14):1449-1456. DOI: 10.1212/WNL.0000000000003173. View

4.
Irani S, Gelfand J, Al-Diwani A, Vincent A . Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol. 2014; 76(2):168-84. PMC: 4141019. DOI: 10.1002/ana.24200. View

5.
Arino H, Armangue T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M . Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome. Neurology. 2016; 87(8):759-65. PMC: 4999321. DOI: 10.1212/WNL.0000000000003009. View